Simris Group
0.19
SEK
+0.26 %
Less than 1K followers
SIMRIS B
First North Stockholm
Food & Beverage
Consumer Goods & Services
Overview
Ownership
Investor consensus
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreMarket cap
118.78M SEK
Turnover
206.81K SEK
Revenue
2.89M
EBIT %
-1,201.04 %
P/E
-
Dividend yield-%
-
Financial calendar
13/8
2025
Interim report Q2'25
12/11
2025
Interim report Q3'25
25/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Simris Group AB Signs Non-Binding Concept Sheet for Potential Antibody-Drug Conjugate Collaboration
Bulletin from Simris Group AB’s annual general meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools